HomeVRDN • NASDAQ
add
Viridian Therapeutics Inc
Previous close
$12.80
Day range
$12.44 - $13.02
Year range
$9.90 - $27.20
Market cap
1.03B USD
Avg Volume
956.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 72.00K | 0.00% |
Operating expense | -150.71M | -70.84% |
Net income | -79.72M | -19.24% |
Net profit margin | -110.73K | -19.24% |
Earnings per share | -0.81 | 40.00% |
EBITDA | -87.35M | -22.46% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 717.58M | 50.32% |
Total assets | 742.40M | 51.38% |
Total liabilities | 70.76M | 46.20% |
Total equity | 671.64M | — |
Shares outstanding | 81.48M | — |
Price to book | 2.15 | — |
Return on assets | -28.88% | — |
Return on capital | -30.68% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -79.72M | -19.24% |
Cash from operations | -73.33M | -92.98% |
Cash from investing | -62.92M | 62.93% |
Cash from financing | 35.52M | -82.14% |
Net change in cash | -100.72M | -1,048.49% |
Free cash flow | -47.50M | -223.40% |
About
Founded
2010
Headquarters
Website
Employees
143
